Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease

Communicable respiratory infections are the cause of a significant number of infectious diseases. The introduction of vaccinations has greatly improved this situation. Moreover, adjuvants have allowed for vaccines to be more effective with fewer adverse side effects. However, there is still space fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dedloff, Margaret R., Effler, Callie S., Holban, Alina Maria, Gestal, Monica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695719/
https://www.ncbi.nlm.nih.gov/pubmed/31370286
http://dx.doi.org/10.3390/ma12152445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695719/
https://www.ncbi.nlm.nih.gov/pubmed/31370286
http://dx.doi.org/10.3390/ma12152445

Ejemplares similares